Truist Financial’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-680
| Closed | -$6.64K | – | 2509 |
|
|
2024
Q3 | $6.64K | Hold |
680
| – | – | ﹤0.01% | 2473 |
|
|
2024
Q2 | $13.9K | Hold |
680
| – | – | ﹤0.01% | 2618 |
|
|
2024
Q1 | $30.7K | Hold |
680
| – | – | ﹤0.01% | 2584 |
|
|
2023
Q4 | $32.1K | Buy |
+680
| New | +$32.1K | ﹤0.01% | 2594 |
|
|
2023
Q3 | – | Sell |
-710
| Closed | -$75.6K | – | 2581 |
|
|
2023
Q2 | $75.6K | Hold |
710
| – | – | ﹤0.01% | 2515 |
|
|
2023
Q1 | $212K | Sell |
710
-36
| -5% | -$10.7K | ﹤0.01% | 2385 |
|
|
2022
Q4 | $256K | Sell |
746
-711
| -49% | -$244K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $275K | Buy |
1,457
+209
| +17% | +$39.4K | ﹤0.01% | 2120 |
|
|
2022
Q2 | $264K | Buy |
1,248
+43
| +4% | +$9.1K | ﹤0.01% | 2281 |
|
|
2022
Q1 | $403K | Buy |
+1,205
| New | +$403K | ﹤0.01% | 2110 |
|
|
2020
Q4 | – | Sell |
-1,326
| Closed | -$920K | – | 2524 |
|
|
2020
Q3 | $920K | Buy |
1,326
+1,063
| +404% | +$738K | ﹤0.01% | 1398 |
|
|
2020
Q2 | $223K | Buy |
+263
| New | +$223K | ﹤0.01% | 2102 |
|